|
Market Closed -
Nasdaq
21:00:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.230 USD | -9.23% |
|
-10.57% | +197.89% |
| 08-19 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
| 08-13 | Edesa Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 | CI |
Company Valuation: Edesa Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 57.15 | - | - |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 228.79% | - | - |
| Enterprise Value (EV) | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 57.15 | 57.15 | 57.15 |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 228.79% | 0% | 0% |
| P/E | -6.71x | -0.88x | -1.51x | -2.31x | -1.94x | -2.13x | -2.05x | -2.06x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.19x | 0x | 0.1x | 0.1x | -0x | -0.51x | 2.55x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 2.46x |
| EV / Revenue | - | - | - | - | - | - | - | 2.46x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.19x | -1.93x | -1.74x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.7 | -7.35 | -2.93 | -1.93 | -1.27 | -1.987 | -2.067 | -2.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 23.26 |
| EBITDA | -23.56 | - | - | - | - | - | - | - |
| EBIT 1 | -23.68 | -18.37 | -9.223 | -7.015 | -7.912 | -17.93 | -29.65 | -32.89 |
| Net income 1 | -13.34 | -17.55 | -8.374 | -6.17 | -7.186 | -17.52 | -29.25 | -32.64 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 51.660 | 6.449 | 4.424 | 4.450 | 2.470 | 4.230 | 4.230 | 4.230 |
| Nbr of stocks (in thousands) | 1,894 | 2,209 | 3,013 | 3,247 | 7,038 | 13,512 | - | - |
| Announcement Date | 28/12/21 | 16/12/22 | 15/12/23 | 13/12/24 | 12/12/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13x | - | - | - | 57.15M | |
| 19.64x | 6.93x | 13.92x | 1.51% | 66.93B | |
| 31.94x | 9.24x | 44.54x | 0.04% | 61.97B | |
| -79.21x | 15.29x | -73.77x | -.--% | 28.26B | |
| 28.46x | 6.03x | 15.64x | -.--% | 24.59B | |
| -14.63x | 5.3x | -6.66x | -.--% | 24.3B | |
| 26.45x | 4.98x | 16.56x | -.--% | 19.41B | |
| 48.28x | 17.79x | 36.09x | 0.31% | 16.77B | |
| 1225.47x | 35.26x | 769.42x | -.--% | 14.18B | |
| -15x | 3382.33x | -17.29x | -.--% | 14B | |
| Average | 126.93x | 387.02x | 88.72x | 0.21% | 27.05B | |
| Weighted average by Cap. | 73.53x | 184.88x | 49.64x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EDSA Stock
- Valuation Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
